Wharton's Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM
Kassem, Dina; Kamal, Mohamed;
Abstract
Diabetes mellitus (DM) is a devastating metabolic disease. Stem cell therapy provides great hope to all diabetic patients. Umbilical cord (UC) Wharton's jelly mesenchymal stem cells (WJ-MSCs) specifically provides a potential cell therapy for DM. In this article, we discuss major advantages of WJ-MSCs and challenges facing their clinical utility in DM.
Other data
| Title | Wharton's Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM | Authors | Kassem, Dina ; Kamal, Mohamed | Keywords | diabetes mellitus;insulin-producing cells;mesenchymal stem cells;Wharton's jelly | Issue Date | 1-Apr-2020 | Publisher | ELSEVIER SCIENCE LONDON | Journal | Trends in Endocrinology and Metabolism | Volume | 31 | Issue | 4 | Start page | 271 | End page | 273 | ISSN | 10432760 | DOI | 10.1016/j.tem.2020.01.001 | PubMed ID | 32035737 | Scopus ID | 2-s2.0-85078933556 | Web of science ID | WOS:000520597900002 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.